학술논문

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
Document Type
Article
Source
In: BMC Cancer. (BMC Cancer, 12 December 2015, 15(1))
Subject
Language
English
ISSN
14712407